$MLYS news
The latest MLYS stock news: headlines, filings, AI summaries and sentiment for $MLYS, updated around the clock.
- Mineralys Therapeutics Outlines December PDUFA Date and Lorundrostat Launch Strategy
- Mineralys Therapeutics Reports Q3 GAAP EPS Miss
- Mineralys Therapeutics, Inc. - 10-Q Filing
- Mineralys Therapeutics, Inc. - 8-K Filing
- Mineralys Therapeutics, Inc. - 8-K Filing
- Mineralys Therapeutics, Inc. - 8-K Filing
- Mineralys Insider Realizes $557K Options Gain Ahead of December FDA Date
- Mineralys CEO Sells Shares Ahead of December FDA Date
- Mineralys Insider Realizes $557K Options Gain Before FDA Date
- Insider Sale at Mineralys Therapeutics Before December FDA Date
- Mineralys Therapeutics Prices $150M Public Offering of Common Stock
- Mineralys Therapeutics Shares Positive Clinical Data for Lorundrostat
- Mineralys Therapeutics, Inc. - 8-K Filing
- Velan Capital Sells $4.1 Million Worth of Shares in Mineralys Therapeutics
- Velan Capital Sells $4.1 Million Worth of Mineralys Therapeutics Shares
- Mineralys Therapeutics, Inc. - 8-K Filing
- Mineralys (MLYS) Q1 2026 Earnings Call Summary